Press release
Irrigated Ablation Catheter Market Explored in Latest Research
In February 2016, irrigated ablation catheter manufactured by Boston Scientific Corporation, received the approval from the U.S. Food and Drug Administration. Irrigated ablation catheter is used to diagnose and treat a condition called type I atrial flutter. Atrial flutter is the condition the cause heart to beat too fast leading to heart failure or stroke. Some of the common symptoms include palpitations, presyncope, mild dyspnea, and fatigue. Irrigation ablation catheter uses total tip cooling technology that is used to cool the catheter tip during the ablation procedure. In open irrigation catheter, radiofrequency energy is used to destroy the place in the tissue that causes atrial flutter.
Request for TOC @ https://www.persistencemarketresearch.com/toc/12178
Technological advancements, advanced product pipeline and growing awareness of patient safety and monitoring are some of the key drivers that are fuelling the growth of irrigated ablation catheter market. However, high research and development expenses in product development and the low awareness about irrigated ablation catheter in the developing countries is anticipated to hamper the growth of irrigated ablation catheter market. According to National Center for Chronic Disease Prevention and Health Promotion, atrial fibrillation cost $6 billion each year in the United States. Medical expenses of people suffering from atrial fibrillation are about $8,705 higher per year compare to people who do not have atrial fibrillation.
Based on the energy source, global irrigated ablation catheter market is segmented into radiofrequency (RF), cryoablation, laser and other energy sources. Radiofrequency (RF) segment is gaining importance in global irrigated ablation catheter market, as radiofrequency ablation (RFA) catheter is used for patients who do not respond to medication. Radiofrequency (RF) energy is used to remove the affected tissue and is marked as a 2nd generation catheter technology.
Ablation by radiofrequency with irrigated tip catheter decreases the possibility of thrombus and help in the creation of larger lesions. According to Centers for Disease Control and Prevention, 2.7–6.1 million people in the United States have atrial fibrillation which is expected to increase with the aging population. African Americans are less likely to have atrial fibrillation than those of European descent. Women show a higher prevalence of atrial fibrillation than men.
Based on catheter types, global irrigated ablation catheter market is segmented into single point radiofrequency catheters, multielectrode radiofrequency catheters, contact force sensing radiofrequency catheters and balloon catheters.
On the basis of regional presence, global irrigated ablation catheter market is segmented into five key regions viz. North America, Latin America, Europe, Asia-Pacific, and the Middle East & Africa. North America is expected to lead the global irrigated ablation catheter market owing to advanced healthcare infrastructure, higher adoption of technologies, and availability of reimbursement policies.
Make an Enquiry @ https://www.persistencemarketresearch.com/samples/12178
Some of the major players in global irrigated ablation catheter market are Boston Scientific Corporation, Osypka AG, Biosense Webster, Inc., and others. New technologically advanced products and systems being launched in the global market, along with expansion in the emerging markets is the primary strategy adopted by major players in the global ablation catheter system market.
About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance. To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Contact Us
Persistence Market Research
305 Broadway,7th Floor
New York City, NY 10007
United States
T: +1-646-568-7751
Tollfree: +1 800-961-0353
Email: sales@persistencemarketresearch.com
Web: www.persistencemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Irrigated Ablation Catheter Market Explored in Latest Research here
News-ID: 808792 • Views: …
More Releases from Persistence Market Research
Vaginitis Treatment Drug Market Growth Accelerated by Rising Awareness of Women' …
The global vaginitis treatment drug market is experiencing consistent growth, reflecting the growing global emphasis on women's reproductive health and wellness. Valued at approximately US$3.3 billion in 2024, the market is expected to reach US$5.3 billion by 2031, registering a compound annual growth rate (CAGR) of 5.0% during the forecast period (2024-2031). This steady expansion is attributed to multiple factors including the rising prevalence of bacterial vaginosis (BV), yeast infections,…
Assembly Line Solutions Market Poised for 7.3% CAGR Growth Through 2032, Says Pe …
The global Assembly Line Solutions Market is witnessing a profound transformation, driven by the accelerating adoption of automation and smart manufacturing technologies across industrial sectors. The market, valued at US$294.5 billion in 2025, is projected to reach approximately US$483.5 billion by 2032, expanding at a robust CAGR of 7.3% over the forecast period (2025-2032). This growth reflects the rising demand for intelligent manufacturing systems that can enhance productivity, minimize downtime,…
Retinal Biologics Market to Reach New Heights with Rising AMD Cases, Says Persis …
The global retinal biologics market is witnessing dynamic transformation, driven by an aging population, rising prevalence of retinal diseases, and advances in biotechnology. Retinal biologics are therapeutic agents derived from living organisms that target the underlying molecular mechanisms responsible for retinal disorders. These biologics, such as Eylea (aflibercept), Lucentis (ranibizumab), and Vabysmo (faricimab-svoa), have revolutionized the management of conditions like age-related macular degeneration (AMD), diabetic retinopathy, and diabetic macular edema…
Neuroendocrine Carcinoma Treatment Market Growth Driven by Novel Therapies, Says …
Neuroendocrine carcinoma (NEC) is a rare and complex cancer that arises from neuroendocrine cells, which are spread across various organs in the body, including the gastrointestinal tract, pancreas, and lungs. As a result, the treatment landscape for NEC is multifaceted, involving a range of therapeutic modalities including surgery, chemotherapy, targeted therapy, immunotherapy, and radioligand therapy. The global market for neuroendocrine carcinoma treatment has seen significant growth over the past decade,…
More Releases for Ablation
Thyroid Ablation Devices Market
Alarming rise in prevalence of thyroid cancer, advancements in thyroid ablation system, rise in government & private funds for development of healthcare sectors, and increase in number of thyroid nodule cases are expected to notably contribute toward the growth of the global thyroid ablation devices market during the forecast period.
Rise in prevalence of thyroid cancer and thyroid nodules, demand for minimally invasive procedures, and technological advancements in ablation devices drive…
Atrial Fibrillation (AF) Ablation Market by Procedure (Catheter Ablation, Surgic …
Arterial fibrillation is a disease that creates irregular and rapid heart rate. Atrial fibrillation ablation is performed to treat the disease. The upper chambers of the heart beat irregularly and contract randomly at a very fast rate, out of coordination with the lower ventricles of the heart due to which the time decreases for the heart muscle relaxation. This increases the rate of heart failure and heart strokes and reduces…
Cardiac Ablation Technologies Market
Growing acceptance of catheter ablation as the first line of therapy, along with recent developments introducing robotic catheter navigation systems and 3D electro-anatomical mapping systems creates a highly conducive environment for the growth of the cardiac ablation technologies market. However, an extensive study published by Fact.MR raises concerns regarding technical complexity leading to lack of required operational competency, which leads to fundamental barriers to the adoption of advanced ablation systems.
Request…
Radiofrequency Ablation Devices Market: Emerging Applications of Radiofrequency …
Radiofrequency ablation is a minimally invasive technique that uses heat and electrical energy to destroy cancer cells and other dysfunctional tissues. Recently, it has been used to treat a wide range of medical conditions. Although it is not a primary treatment of cancer, it is used to treat a spot of tumor causing pain and other medical indications. The technique is also used to treat patients suffering from adrenal gland,…
Nerve Ablation Devices Market to Record an Exponential CAGR by 2028(Based on pro …
Nerves are the vital part of the body, responsible for carrying signals from different parts of the body to the brain. The nerves carry electrical signals that act on actions such as pain and other movements of the body. The nerve ablation devices are used to treat patient by minimally invasive procedures, where a microelectrode is inserted inside the patient to heat the nerve tissue. The nerve ablation devices help…
Interventional Oncology Solutions Market Ablation Radiofrequency Ablation, Cryo …
Interventional oncology is a field of medical science, which includes treatment and diagnosis of cancer and other problems related to cancer using minimally invasive procedures. Interventional oncology uses various techniques such as Ultrasound, computed tomography, X-ray, and magnetic resonance imaging (MRI) to treat tumors located in various organs of the body. Interventional oncology procedures are usually used to treat metastatic or primary cancer. These procedures can be used to treat…
